216 related articles for article (PubMed ID: 29666117)
1. Novel insights into the pathogenesis of T-cell lymphomas.
Van Arnam JS; Lim MS; Elenitoba-Johnson KSJ
Blood; 2018 May; 131(21):2320-2330. PubMed ID: 29666117
[TBL] [Abstract][Full Text] [Related]
2. The curious origins of angioimmunoblastic T-cell lymphoma.
Cortés JR; Palomero T
Curr Opin Hematol; 2016 Jul; 23(4):434-43. PubMed ID: 27177312
[TBL] [Abstract][Full Text] [Related]
3. Approach to nodal-based T-cell lymphomas.
de Leval L
Pathology; 2020 Jan; 52(1):78-99. PubMed ID: 31785821
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
5. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
[TBL] [Abstract][Full Text] [Related]
6. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
Sandell RF; Boddicker RL; Feldman AL
Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2019; 60(9):1221-1228. PubMed ID: 31597847
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCL.
Zing NPC; Fischer T; Zain J; Federico M; Rosen ST
Oncology (Williston Park); 2018 Jul; 32(7):e74-e82. PubMed ID: 30080923
[TBL] [Abstract][Full Text] [Related]
10. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
Timmins MA; Wagner SD; Ahearne MJ
Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of T-cell lymphomas.
de Leval L; Bisig B; Thielen C; Boniver J; Gaulard P
Crit Rev Oncol Hematol; 2009 Nov; 72(2):125-43. PubMed ID: 19233683
[TBL] [Abstract][Full Text] [Related]
12. T-cell lymphoma: Microenvironment-related biomarkers.
Tse E; Kwong YL
Semin Cancer Biol; 2015 Oct; 34():46-51. PubMed ID: 26057207
[TBL] [Abstract][Full Text] [Related]
13. Natural killer/T-cell lymphomas in pediatric and adolescent patients.
Termuhlen AM
Clin Adv Hematol Oncol; 2017 Mar; 15(3):200-209. PubMed ID: 28398275
[TBL] [Abstract][Full Text] [Related]
14. Concepts in mature T-cell lymphomas - highlights from an international joint symposium on T-cell immunology and oncology.
Herling M; Rengstl B; Scholtysik R; Hartmann S; Küppers R; Hansmann ML; Diebner HH; Roeder I; Abken H; Newrzela S; Kirberg J
Leuk Lymphoma; 2017 Apr; 58(4):788-796. PubMed ID: 27643643
[TBL] [Abstract][Full Text] [Related]
15. An update on genetic aberrations in T-cell neoplasms.
Parilla M; Quesada AE; Medeiros LJ; Thakral B
Pathology; 2023 Apr; 55(3):287-301. PubMed ID: 36801152
[TBL] [Abstract][Full Text] [Related]
16. SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas.
Qiu L; Cho JH; Jelloul FZ; Vega F
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):287-296. PubMed ID: 34776400
[TBL] [Abstract][Full Text] [Related]
17. Challenges and implications of genomics for T-cell lymphomas.
Jacobsen ED; Weinstock DM
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):63-68. PubMed ID: 30504292
[TBL] [Abstract][Full Text] [Related]
18. Biological insights into the role of TET2 in T cell lymphomas.
Carty SA
Front Oncol; 2023; 13():1199108. PubMed ID: 37841428
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.
Martinez-Delgado B; Meléndez B; Cuadros M; Alvarez J; Castrillo JM; Ruiz De La Parte A; Mollejo M; Bellas C; Diaz R; Lombardía L; Al-Shahrour F; Domínguez O; Cascon A; Robledo M; Rivas C; Benitez J
Clin Cancer Res; 2004 Aug; 10(15):4971-82. PubMed ID: 15297397
[TBL] [Abstract][Full Text] [Related]
20. Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.
Carras S; Chartoire D; Mareschal S; Heiblig M; Marçais A; Robinot R; Urb M; Pommier RM; Julia E; Chebel A; Verney A; Bertheau C; Bardel E; Fezelot C; Courtois L; Lours C; Bouska A; Sharma S; Lefebvre C; Rouault JP; Sibon D; Ferrari A; Iqbal J; de Leval L; Gaulard P; Traverse-Glehen A; Sujobert P; Blery M; Salles G; Walzer T; Bachy E; Genestier L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34043588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
